Top Markets
#1 The Bitcoin Bull The Bitcoin Bull +30.78%
#2 Tellor Tributes Tellor Tributes +19.85%
#3 EXOD EXOD +18.93%
#4 Official Trump Official Trump +16.49%
#5 Dash Dash +14.13%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +13.95%
#7 Horizen Horizen +13.74%
#8 Decred Decred +12.45%
#9 ApeX ApeX +12.06%
#10 Binance-Peg ZEC Binance-Peg ZEC +11.88%
Coin of the day
The Bitcoin Bull The Bitcoin Bull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
G&E Herbal Biotechnology Co., Ltd. G&E Herbal Biotechnology Co., Ltd.

G&E Herbal Biotechnology Co., Ltd.

4911
Classifica tra le azioni #24234
G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise,... G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
Prezzo delle azioni
$0.91899191
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$63.24M
Variazione (1 giorno)
0.17%
Variazione (1 anno)
-39.70%
Paese
CN
Scambia G&E Herbal Biotechnology Co., Ltd. (4911)

Categoria

Healthcare
Ricavi di G&E Herbal Biotechnology Co., Ltd. (4911)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di G&E Herbal Biotechnology Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per G&E Herbal Biotechnology Co., Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH